Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200060369Phase 4Recruiting
Phase 4, randomised trial of salbutamol in respiratory complication (2 arms), sponsored by Taizhou People's Hospital. Primary endpoint: Respiratory complications. Started May 2022; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200060369.